文献速递脑血管病

缺血性卒中后骨折风险预测评分在加拿大队列中的推导与外部验证

Derivation and External Validation of a Scoring System for Predicting Fracture Risk After Ischemic Stroke in a Canadian Cohort.
PubMed 文献 · JAMA Neurol · 2019-01-01

该研究基于安大略卒中登记队列推导并外部验证了FRAC-Stroke评分,用于预测缺血性卒中出院后1年内低创伤性骨折风险。评分有助于识别高风险患者以选择预防骨折的干预措施。

要点

  • FRAC-Stroke评分纳入年龄、出院mRS及类风湿关节炎、骨质疏松、跌倒史和既往骨折史。
  • 验证队列中C统计量为0.70,评分五分位从低到高1年低创伤性骨折累积发生率由1.3%升至9.0%。
  • 出院mRS是重要风险区分因素,mRS 3和4患者风险最高,而卧床患者(mRS 5)风险最低。

核心结论

  • FRAC-Stroke评分可识别缺血性卒中出院后1年内低创伤性骨折高风险患者,可能用于选择预防骨折的干预人群。

研究设计与样本

  • 预后研究:推导队列来自安大略卒中登记,纳入2003年7月1日至2012年3月31日因缺血性卒中住院的成人,随访1年。
  • 使用Fine-Gray竞争风险回归推导评分,预测变量基于生物学合理性和与骨折风险的关联选择。

主要发现

  • 年龄、出院mRS以及类风湿关节炎、骨质疏松、跌倒史和既往骨折史与低创伤性骨折累积发生率相关。
  • 出院mRS是重要风险区分因素(相对综合判别改善8.7%),mRS 3和4患者风险最高,卧床患者(mRS 5)风险最低。
  • 验证队列中FRAC-Stroke五分位从最低到最高,1年低创伤性骨折累积发生率从1.3%增至9.0%,预测与观察骨折率相似。

关键数值与推荐

  • FRAC-Stroke评分预测缺血性卒中出院后1年内低创伤性骨折,验证队列C统计量0.70。
  • 验证队列评分五分位1年低创伤性骨折累积发生率:最低五分位1.3%,最高五分位9.0%。
  • 出院mRS相对综合判别改善8.7%。

临床怎么用

  • 临床医生可使用FRAC-Stroke评分识别缺血性卒中出院后1年内低创伤性骨折高风险患者。
  • 评分信息可能用于选择患者进行预防骨折的干预。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The risk for low-trauma fracture is increased by more than 30% after ischemic stroke, but existing fracture risk scores do not account for history of stroke as a high-risk condition. OBJECTIVE: To derive a risk score to predict the probability of fracture within 1 year after ischemic stroke and validate it in a separate cohort. DESIGN, SETTING, AND PARTICIPANTS: Prognostic study of a cohort from the Ontario Stroke Registry, a population-based sample of adults in Ontario, Canada, who were hospitalized with ischemic stroke from July 1, 2003, to March 31, 2012, with 1 year of follow-up. A population-based validation cohort consisted of a sample of 13 698 consecutive stroke admissions captured across 5 years: April 2002 to March 2003, April 2004 to March 2005, April 2008 to March 2009, April 2010 to March 2011, and April 2012 to March 2013. EXPOSURES: Predictor variables were selected based on biological plausibility and association with fracture risk. Age, sex, and modified Rankin score were abstracted from the medical records part of the Ontario Stroke Audit, and other characteristics were abstracted from administrative health data. MAIN OUTCOMES AND MEASURES: Incidence of low-trauma fracture within 1 year of discharge, based on administrative health data. RESULTS: The Fracture Risk after Ischemic Stroke (FRAC-Stroke) Score was derived in 20 435 patients hospitalized for ischemic stroke (mean [SD] age, 71.6 [14.0] years; 9564 [46.8%] women) from the Ontario Stroke Registry discharged from July 1, 2003, to March 31, 2012, using Fine-Gray competing risk regression. Low-trauma fracture occurred within 1 year of discharge in 741 of the 20 435 patients (3.6%) in the derivation cohort. Age, discharge modified Rankin score (mRS), and history of rheumatoid arthritis, osteoporosis, falls, and previous fracture were associated with the cumulative incidence of low trauma fracture in the derivation cohort. Model discrimination in the validation cohort (n = 13 698) was good (C statistic, 0.70). Discharge mRS was an important discriminator of risk (relative integrated discrimination improvement, 8.7%), with highest risk in patients with mRS 3 and 4 but lowest in bedbound patients (mRS 5). From the lowest to the highest FRAC-Stroke quintile, the cumulative incidence of 1-year low-trauma fracture increased from 1.3% to 9.0% in the validation cohort. Predicted and observed rates of fracture were similar in the external validation cohort. Analysis was conducted from July 2016 to January 2019. CONCLUSIONS AND RELEVANCE: The FRAC-Stroke score allows the clinician to identify ischemic stroke survivors at higher risk of low-trauma fracture within 1 year of hospital discharge. This information might be used to select patients for interventions to prevent fractures.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Smith EE, Fang J, Alibhai SM, et al. Derivation and External Validation of a Scoring System for Predicting Fracture Risk After Ischemic Stroke in a Canadian Cohort. JAMA Neurol. 2019. PMID: 31081876. doi:10.1001/jamaneurol.2019.1114

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。